Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
There are limited numbers of models to study hepatocellular carcinoma (HCC) in vivo in immunocompetent hosts. In an effort to develop a cell line with improved tumorigenicity, we derived a new cell line from Hepa1-6 cells through an in vivo passage in C57BL/6 mice. The resulting Dt81Hepa1-6 cell lin...
Main Authors: | Benoit Lacoste, Valérie-Ann Raymond, Shamir Cassim, Pascal Lapierre, Marc Bilodeau |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5289561?pdf=render |
Similar Items
-
Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes.
by: Benoit Lacoste, et al.
Published: (2016-01-01) -
From in vivo to in vitro: Major metabolic alterations take place in hepatocytes during and following isolation.
by: Shamir Cassim, et al.
Published: (2017-01-01) -
UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
by: Yanchen Wang, et al.
Published: (2023-06-01) -
Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7
by: Mustafa Karabicici, et al.
Published: (2021-08-01) -
Rapamycin response in tumorigenic and non-tumorigenic hepatic cell lines.
by: Rosa H Jimenez, et al.
Published: (2009-10-01)